X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14039) 14039
Publication (1429) 1429
Book Review (224) 224
Book Chapter (59) 59
Conference Proceeding (20) 20
Magazine Article (13) 13
Dissertation (11) 11
Reference (3) 3
Book / eBook (2) 2
Government Document (2) 2
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (8432) 8432
humans (6808) 6808
male (6566) 6566
index medicus (5971) 5971
female (4032) 4032
rats (3942) 3942
mice (3218) 3218
cyclooxygenase 2 - metabolism (3022) 3022
pharmacology & pharmacy (2954) 2954
cyclooxygenase inhibitors - pharmacology (2889) 2889
cyclooxygenase 2 (2159) 2159
inflammation (2155) 2155
cyclooxygenase-2 (2132) 2132
cox-2 inhibitors (2121) 2121
cyclooxygenase (2104) 2104
celecoxib (1946) 1946
nonsteroidal antiinflammatory drugs (1907) 1907
expression (1789) 1789
adult (1580) 1580
middle aged (1575) 1575
dose-response relationship, drug (1573) 1573
cyclooxygenase inhibitors - therapeutic use (1482) 1482
rats, sprague-dawley (1481) 1481
rats, wistar (1386) 1386
cox-2 (1332) 1332
prostaglandin-endoperoxide synthases - metabolism (1305) 1305
membrane proteins (1298) 1298
cyclooxygenase 2 inhibitors (1261) 1261
disease models, animal (1259) 1259
prostaglandins (1256) 1256
cyclooxygenase 2 - genetics (1222) 1222
aged (1213) 1213
biochemistry & molecular biology (1160) 1160
analysis (1145) 1145
cyclooxygenase 2 inhibitors - pharmacology (1140) 1140
inhibition (1139) 1139
anti-inflammatory agents, non-steroidal - pharmacology (1119) 1119
indomethacin - pharmacology (1113) 1113
cyclooxygenase inhibitors - administration & dosage (1101) 1101
oncology (1091) 1091
neurosciences (1087) 1087
anti-inflammatory agents, non-steroidal - therapeutic use (1086) 1086
nitric oxide (1041) 1041
anti-inflammatory agents, non-steroidal - adverse effects (1039) 1039
sulfonamides - pharmacology (1012) 1012
cyclooxygenase 2 inhibitors - therapeutic use (998) 998
dinoprostone - metabolism (949) 949
research (931) 931
cancer (928) 928
indomethacin (920) 920
aspirin (916) 916
apoptosis (881) 881
cyclooxygenase inhibitors - adverse effects (879) 879
time factors (865) 865
cyclooxygenase 2 inhibitors - administration & dosage (847) 847
cell biology (844) 844
nitric-oxide synthase (838) 838
nitric-oxide (825) 825
immunology (818) 818
physiology (799) 799
cyclooxygenase inhibitors (793) 793
isoenzymes - metabolism (781) 781
rheumatoid-arthritis (774) 774
oxidative stress (767) 767
treatment outcome (757) 757
cells (756) 756
nonsteroidal anti-inflammatory drugs (756) 756
activation (742) 742
isoenzymes - antagonists & inhibitors (741) 741
rodents (728) 728
nf-kappa-b (726) 726
anti-inflammatory agents, non-steroidal - administration & dosage (725) 725
care and treatment (714) 714
cells, cultured (713) 713
chemistry, medicinal (708) 708
mice, inbred c57bl (700) 700
physiological aspects (674) 674
cyclooxygenase 2 inhibitors - adverse effects (673) 673
immunohistochemistry (670) 670
nf-kappa b - metabolism (661) 661
in-vitro (658) 658
risk factors (658) 658
anti-inflammatory agents - pharmacology (657) 657
article (651) 651
double-blind method (647) 647
rat (633) 633
sulfonamides - therapeutic use (631) 631
enzymes (627) 627
cyclooxygenase 1 - metabolism (625) 625
medicine & public health (625) 625
pyrazoles - pharmacology (624) 624
health aspects (621) 621
cyclooxygenase 1 (616) 616
sulfonamides - administration & dosage (607) 607
nitric oxide synthase type ii - metabolism (605) 605
administration, oral (604) 604
pain (604) 604
prevention (595) 595
rofecoxib (594) 594
enzyme inhibitors - pharmacology (571) 571
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13868) 13868
German (59) 59
Japanese (36) 36
French (35) 35
Chinese (32) 32
Russian (24) 24
Spanish (17) 17
Italian (8) 8
Polish (6) 6
Norwegian (5) 5
Korean (4) 4
Swedish (3) 3
Turkish (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Czech (2) 2
Portuguese (2) 2
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Hungarian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Depression and Anxiety, ISSN 1091-4269, 07/2009, Volume 26, Issue 7, pp. 607 - 611
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2006, Volume 355, Issue 9, pp. 873 - 884
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 07/2006, Volume 11, Issue 7, pp. 680 - 684
Signs of an inflammatory process, in particular increased pro-inflammatory cytokines and increased levels of prostaglandine E-2 ( PGE(2)), have repeatedly been... 
COX-2 inhibition | Inflammation | Psychoneuroimmunology | Major depression | Immunity | SYSTEM | COX-2 | PSYCHIATRY | BIOCHEMISTRY & MOLECULAR BIOLOGY | psychoneuroimmunology | SCHIZOPHRENIA | SICKNESS BEHAVIOR | SYMPTOMS | immunity | NEUROSCIENCES | INFLAMMATORY MARKERS | INTERFERON-ALPHA | PROSTAGLANDINS | inflammation | ROFECOXIB | major depression | BRAIN | Anti-Anxiety Agents - administration & dosage | Dinoprostone - analysis | Pyrazoles - therapeutic use | Adrenergic Uptake Inhibitors | Dinoprostone - biosynthesis | Humans | Middle Aged | Depressive Disorder - drug therapy | Male | Patient Dropouts | Lorazepam - therapeutic use | Inflammation - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Adult | Female | Antidepressive Agents - pharmacology | Anti-Anxiety Agents - therapeutic use | Drug Therapy, Combination | Morpholines - therapeutic use | Pyrazoles - pharmacology | Severity of Illness Index | Cyclooxygenase 2 Inhibitors - pharmacology | Double-Blind Method | Cyclooxygenase 2 Inhibitors - administration & dosage | Morpholines - administration & dosage | Lorazepam - administration & dosage | Celecoxib | Sulfonamides - pharmacology | Antidepressive Agents - therapeutic use | Pilot Projects | Pyrazoles - administration & dosage | Sulfonamides - therapeutic use | Depressive Disorder - physiopathology | Serotonin - metabolism | Interleukin-6 - biosynthesis | Antidepressive Agents - administration & dosage | Psychological Tests | Sulfonamides - administration & dosage | Inflammation - physiopathology
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10087, pp. 2375 - 2382
Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require... 
Internal Medicine | RHEUMATOID-ARTHRITIS | CYCLO-OXYGENASE-2 | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY | DICLOFENAC | PREVENTION | RISK | OSTEOARTHRITIS | Celecoxib - administration & dosage | Recurrence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Secondary Prevention - methods | Aspirin - administration & dosage | Cyclooxygenase 2 Inhibitors - adverse effects | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Aspirin - therapeutic use | Drug Therapy, Combination | Celecoxib - adverse effects | Naproxen - adverse effects | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Cyclooxygenase 2 Inhibitors - administration & dosage | Peptic Ulcer Hemorrhage - chemically induced | Celecoxib - therapeutic use | Proton Pump Inhibitors - therapeutic use | Naproxen - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Aged | Care and treatment | Aspirin | Anti-inflammatory drugs | Gastrointestinal diseases | Naproxen | Clinical trials | Arthritis | Complications and side effects | Medical research | Gastrointestinal bleeding | Medicine, Experimental | Drugs | Funding | Risk | Population studies | Hemorrhage | Bleeding | Incidence | Prostaglandin endoperoxide synthase | Motivation | Safety | Nonsteroidal anti-inflammatory drugs | Antiinflammatory agents | Digestive system | Risk reduction | Inflammation | Celecoxib | Patients | Diseases | Omeprazole | Random numbers | Inhibitors | Ulcers | Healing | Fatalities | Cyclooxygenase-2 | Cardiovascular diseases | Health risk assessment
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2015, Volume 107, Issue 1, p. 345
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2006, Volume 355, Issue 9, pp. 885 - 895
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 10/2007, Volume 96, Issue 10, pp. 2686 - 2702
Journal Article
Journal of Immunology, ISSN 0022-1767, 03/2010, Volume 184, Issue 5, pp. 2449 - 2457
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 11/2017, Volume 38, Issue 44, pp. 3282 - 3292
Journal Article